Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia

Authors

  • Julia ML Brotherton National Centre for Immunisation Research and Surveillance; University of Sydney, New South Wales
  • Shelley L Deeks National Centre for Immunisation Research and Surveillance; University of Sydney, New South Wales
  • Sue Campbell-Lloyd NSW Department of Health, North Sydney, New South Wales
  • Avner Misrachi Communicable Disease Prevention Unit, Department of Health and Human Services, Tasmania
  • Irene Passaris Communicable Disease Control, ACT Health, Australian Capital Territory
  • Karen Peterson Queensland Health, Queensland
  • Helen Pitcher Communicable Disease Control Section, Victorian Government Department of Human Services, Victoria
  • Megan Scully Communicable Disease Control Directorate, WA Department of Health, Western Australia
  • Maureen Watson SA Immunisation Coordination Unit, Communicable Disease Control Branch, Department of Health, South Australia
  • Rosalind Webby Centre for Disease Control, Department of Health and Families, Darwin, Northern Territory

DOI:

https://doi.org/10.33321/cdi.2008.32.45

Keywords:

human papillomavirus immunisation, immunisation coverage, school- based immunisation, Australia, vaccination

Abstract

In November 2006, the Australian Government announced the National HPV Vaccination Program, consisting of a course of prophylactic human papillomavirus (HPV) vaccine for all Australian females aged 12–26 years. Females aged 12–18 years are vaccinated through school-based programs. The school-based component commenced in April 2007, with the school years targeted varying across jurisdictions. Each jurisdiction maintains comprehensive records of HPV doses delivered in the school-based programs although how this is captured varies. This report presents interim coverage estimates for Year 1 (2007) of the program. Both New South Wales and Victoria achieved coverage of 70% or more among almost all school cohorts vaccinated in the program. Some of the variation in coverage achieved may reflect different levels of experience with school-based programs, and varying methods for school-based vaccine delivery and recording of doses administered. Except for some doses in South Australia, these interim coverage estimates do not include catch-up doses delivered by general practitioners or persons who were vaccinated prior to the onset of the program. Therefore, these data should be considered minimum estimates of coverage. The 1st year of the school-based HPV vaccination program should be considered a success, given time and resource constraints. Public sector immunisation providers across Australia should be commended for planning and implementing a new national immunisation program in approximately 4 months. Commun Dis Intell 2008;32:457–461.

Downloads

Download data is not yet available.

References

Brotherton JM, Gold MS, Kemp AS, McIntyre PB, Burgess MA, Campbell-Lloyd S, New South Wales Health HPV Adverse Events Panel. Anaphylaxis following quadrivalent human papillomavirus vaccination. CMAJ 2008;179:525–533.

Buttery JP, Madin S, Crawford NW, Elia S, La Vincente S, Hanieh S, et al. Mass psychogenic response to human papillomavirus vaccination. Med J Aust 2008;189:261–262.

Downloads

Published

01/12/08

How to Cite

Brotherton, Julia ML, Shelley L Deeks, Sue Campbell-Lloyd, Avner Misrachi, Irene Passaris, Karen Peterson, Helen Pitcher, Megan Scully, Maureen Watson, and Rosalind Webby. 2008. “Interim Estimates of Human Papillomavirus Vaccination Coverage in the School-Based Program in Australia”. Communicable Diseases Intelligence 32 (December):457-61. https://doi.org/10.33321/cdi.2008.32.45.

Issue

Section

Surveillance summary

Categories